2000, Number 1
<< Back Next >>
Rev Cent Dermatol Pascua 2000; 9 (1)
Classical Kaposi’s sarcoma
Rosalia CB, Álvarez GV
Language: Spanish
References: 11
Page: 6-10
PDF size: 141.72 Kb.
ABSTRACT
The clinical and histological features of Kaposi’s sarcoma are described. We comment the treatment for clinical state.
REFERENCES
Perniciaro C, Gross D, White J, Adrian R. Familial Kaposi’s Sarcoma. Cutis 1996; 57: 220-222.
Friedman A, Saltzman B. Clinical manifestations of classical, endemic African and Epidemic AIDS-associated Kaposi’s Sarcoma. JAAD 1990; 22: 1237-1248.
Costa C, Ferchat F, Calvo F et al. Long-term Follow-up of Non-HIV Kaposi’s Sarcoma Treated with Low-dose Recombinant Interferon Alfa-2b. Arch Dermatol 1996; 132: 285-290.
Aspiroz C, Saenz C. Herpes virus 8 y sarcoma de Kaposi. Piel 1997; 12: 174-177.
Schwartz R, Spicer M, Thomas I, et al. Ecchymotic Kaposi’s Sarcoma. Cutis 1995; 56: 104-106.
Schwartz R. Kaposi’s Sarcoma: Advances and perspectives. JAAD 1996; 34: 804-814.
Witte M, Stuntz M, Witte C. Kaposi’s sarcoma: A Lymphologic Perspective. Int J Dermatol 1989; 28: 561-568.
García M, García P. Tratamiento actualizado del sarcoma de Kaposi. Piel 1995: 175-185.
Soriano V, Hewlett J. Etiología del Sarcoma de Kaposi. Med Clin 1991; 9: 662-667.
Miralles E, Pérez B, Nuñez M et al. Low-dose Recombinant Interferon alfa-2ª treatment for Classic Kaposi’s Sarcoma. Arch Dermatol 1994; 130: 799-800.
Rappsberg K, Wolff K, Stingl G. Kaposi’s Sarcoma. In: Fitzpatrick TB, Eisen AZS, Wolff K, Freedberg IM, Austen KF, eds: Dermatology in General Medicine, 5ª ed. Nueva York, McGraw-Hill, 199; 1:1195-1204.